{"id":"258845020786-10","name":"Gilead Sciences","registrationDate":"2016-02-23T17:12:58.644+01:00","category":2,"subCategory":3,"legal":"Corporation","web":"http://www.gilead.com","country":"United states","headAddress":"333 Lakeside","headCity":"California","headPostCode":"CA94404","headPhone":"(1)65 05 74 30 00","boss":"Milligan John","bossTitle":"Mr","bossPosition":"President and Chief Executive Officer","membersCount":4,"membersFTE":"1.5","membership":"","memberOrga":"","goal":"Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company?s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide.","acronym":"GILD","interests":"Competition, Economic and Financial Affairs, Enterprise, Public Health, Trade","euInitiatives":"EU initiatives in relation to HIV/AIDS, Hepatitis B &amp; C and oncology. Joint Action on on HIV and co-infection prevention and harm reduction.&#xd;<br />&#xd;<br />ENVI Committee report on access to medicines.&#xd;<br />&#xd;<br />European Council Conclusions on strengthening the balance in the pharmaceutical market and follow-up initiatives.","lastUp":"2017-02-16T15:13:42.030+01:00","customers":"","costAbsolu":"","costRange":"200000-299999","turnoverAbsolu":0,"turnoverRange":""}